Cargando…
Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
BACKGROUND: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in eyes treated with 0.2 µg/day of a fluocinolone...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Virtual Ophthalmic Research Center
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460228/ https://www.ncbi.nlm.nih.gov/pubmed/37641614 http://dx.doi.org/10.51329/mehdioph-thal1421 |
_version_ | 1785097597632905216 |
---|---|
author | Lopes, Beatriz Oliveira Brizido, Margarida Sena Aerts, Florence Pina, Susana Morais Simoes, Pedro Santana Miranda, Margarida Isidoro |
author_facet | Lopes, Beatriz Oliveira Brizido, Margarida Sena Aerts, Florence Pina, Susana Morais Simoes, Pedro Santana Miranda, Margarida Isidoro |
author_sort | Lopes, Beatriz Oliveira |
collection | PubMed |
description | BACKGROUND: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in eyes treated with 0.2 µg/day of a fluocinolone acetonide intravitreal implant (FAc) after an insufficient response to previous treatments. METHODS: This was a retrospective comparative study of 18 eyes (15 patients) with persistent and/or recurrent diabetic macular edema (DME) treated with FAc. Eyes were divided according to the number of prior intravitreal treatments: group 1 (n = 8) with ≤ 6 injections (early switch) and group 2 (n = 10) with > 6 injections (late switch). Outcomes included percentage of eyes with DRIL and/or EZ disruption at baseline and analysis of the best corrected visual acuity (BCVA) using ETDRS letters, central macular thickness (CMT), DRIL, and EZ disruption at the last observation. RESULTS: Group 2 revealed a significantly higher percentage of DRIL and/or EZ disruption than group 1 (P < 0.05). At the last observation, group 1 revealed a higher percentage of eyes achieving vision stability/ improvement, gaining ≥ 15 letters, and achieving ≥70 letters (P > 0.05 for all comparisons). The mean BCVA gain was 8.8 and 0.7 letters for groups 1 and 2 (P = 0.397). Both groups revealed a significant mean CMT reduction (> 20% reduction from the baseline value), without a significant statistical difference between them (P = 0.749). After treatment, most eyes from both groups showed resolution of DRIL and EZ disruption. CONCLUSIONS: Patients with DME presenting with a lower percentage of DRIL and/or EZ disruption at baseline had better functional outcomes, supporting the possible benefit of an early switch to FAc after insufficient response to previous treatments. Future randomized studies with a larger patient cohort are warranted to confirm our conclusions. |
format | Online Article Text |
id | pubmed-10460228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Virtual Ophthalmic Research Center |
record_format | MEDLINE/PubMed |
spelling | pubmed-104602282023-08-28 Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant Lopes, Beatriz Oliveira Brizido, Margarida Sena Aerts, Florence Pina, Susana Morais Simoes, Pedro Santana Miranda, Margarida Isidoro Med Hypothesis Discov Innov Ophthalmol Article BACKGROUND: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in eyes treated with 0.2 µg/day of a fluocinolone acetonide intravitreal implant (FAc) after an insufficient response to previous treatments. METHODS: This was a retrospective comparative study of 18 eyes (15 patients) with persistent and/or recurrent diabetic macular edema (DME) treated with FAc. Eyes were divided according to the number of prior intravitreal treatments: group 1 (n = 8) with ≤ 6 injections (early switch) and group 2 (n = 10) with > 6 injections (late switch). Outcomes included percentage of eyes with DRIL and/or EZ disruption at baseline and analysis of the best corrected visual acuity (BCVA) using ETDRS letters, central macular thickness (CMT), DRIL, and EZ disruption at the last observation. RESULTS: Group 2 revealed a significantly higher percentage of DRIL and/or EZ disruption than group 1 (P < 0.05). At the last observation, group 1 revealed a higher percentage of eyes achieving vision stability/ improvement, gaining ≥ 15 letters, and achieving ≥70 letters (P > 0.05 for all comparisons). The mean BCVA gain was 8.8 and 0.7 letters for groups 1 and 2 (P = 0.397). Both groups revealed a significant mean CMT reduction (> 20% reduction from the baseline value), without a significant statistical difference between them (P = 0.749). After treatment, most eyes from both groups showed resolution of DRIL and EZ disruption. CONCLUSIONS: Patients with DME presenting with a lower percentage of DRIL and/or EZ disruption at baseline had better functional outcomes, supporting the possible benefit of an early switch to FAc after insufficient response to previous treatments. Future randomized studies with a larger patient cohort are warranted to confirm our conclusions. International Virtual Ophthalmic Research Center 2021-08-05 /pmc/articles/PMC10460228/ /pubmed/37641614 http://dx.doi.org/10.51329/mehdioph-thal1421 Text en © Author(s). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Article Lopes, Beatriz Oliveira Brizido, Margarida Sena Aerts, Florence Pina, Susana Morais Simoes, Pedro Santana Miranda, Margarida Isidoro Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
title | Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
title_full | Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
title_fullStr | Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
title_full_unstemmed | Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
title_short | Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
title_sort | prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460228/ https://www.ncbi.nlm.nih.gov/pubmed/37641614 http://dx.doi.org/10.51329/mehdioph-thal1421 |
work_keys_str_mv | AT lopesbeatrizoliveira prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant AT brizidomargaridasena prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant AT aertsflorence prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant AT pinasusanamorais prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant AT simoespedrosantana prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant AT mirandamargaridaisidoro prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant |